BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8906133)

  • 1. Topotecan hydrochloride for metastatic ovarian cancer.
    Med Lett Drugs Ther; 1996 Oct; 38(986):96-7. PubMed ID: 8906133
    [No Abstract]   [Full Text] [Related]  

  • 2. Topotecan: an important new drug in the management of ovarian cancer.
    Markman M
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-1. PubMed ID: 9122736
    [No Abstract]   [Full Text] [Related]  

  • 3. Topotecan approved for cancer chemotherapy.
    Am J Health Syst Pharm; 1996 Aug; 53(15):1763-4. PubMed ID: 8842305
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.
    ten Bokkel Huinink W; Carmichael J; Armstrong D; Gordon A; Malfetano J
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-19-S5-25. PubMed ID: 9122738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topotecan in platinum- and paclitaxel-resistant ovarian cancer.
    Swisher EM; Mutch DG; Rader JS; Elbendary A; Herzog TJ
    Gynecol Oncol; 1997 Sep; 66(3):480-6. PubMed ID: 9299264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topotecan and the treatment of recurrent ovarian cancer: is there a role for granulocyte colony-stimulating factor?
    Saltz L; Janik JE
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-26-S5-30. PubMed ID: 9122740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line therapy.
    Nurs Stand; 1997 Feb; 11(21):28. PubMed ID: 9110778
    [No Abstract]   [Full Text] [Related]  

  • 8. New options for the treatment of advanced ovarian cancer.
    Dunton CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ovarian cancer. The new chemotherapeutic agents].
    Catimel G; Talon A
    Soins; 1995 Oct; (599):20-2, 24-5. PubMed ID: 8701349
    [No Abstract]   [Full Text] [Related]  

  • 10. Topotecan and PML: the limits of pharmaceutical industry research.
    Learned J
    Notes Undergr; 1996 Sep; (No 33):1-3. PubMed ID: 11363913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase II clinical study of topotecan hydrochloride in patients with recurrent advanced ovarian cancer].
    Li JD; Guan ZZ; Liu JH; Xin XY; Cui Y; Huang CJ; Liu FY; Song L; Bian ML; Zhou QH
    Ai Zheng; 2002 Apr; 21(4):416-20. PubMed ID: 12452024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.
    Dark GG; Calvert AH; Grimshaw R; Poole C; Swenerton K; Kaye S; Coleman R; Jayson G; Le T; Ellard S; Trudeau M; Vasey P; Hamilton M; Cameron T; Barrett E; Walsh W; McIntosh L; Eisenhauer EA
    J Clin Oncol; 2005 Mar; 23(9):1859-66. PubMed ID: 15699482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topotecan now available for HIV, PML research.
    AIDS Treat News; 1995 Apr; (no 220):4. PubMed ID: 11362319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topotecan demonstrates significant activity in small-cell lung cancer.
    Oncology (Williston Park); 1996 Mar; 10(3):422-3. PubMed ID: 8820456
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials referral resource. Trials of topotecan.
    Cheson BD; Phillips PH; Arbuck SG
    Oncology (Williston Park); 1995 Mar; 9(3):220, 224-6, 228. PubMed ID: 7669515
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemosensitivity testing of topotecan as second-line agent in chemotherapy of ovarian cancer].
    Qian XL; Peng ZL; Liu SL
    Ai Zheng; 2003 Dec; 22(12):1352-4. PubMed ID: 14693068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer.
    Seiden MV; Muggia F; Astrow A; Matulonis U; Campos S; Roche M; Sivret J; Rusk J; Barrett E
    Gynecol Oncol; 2004 Apr; 93(1):229-32. PubMed ID: 15047241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials referral resource. Clinical trials with topotecan.
    Cheson BD; Arbuck SG
    Oncology (Williston Park); 1993 Feb; 7(2):49-51. PubMed ID: 8439468
    [No Abstract]   [Full Text] [Related]  

  • 19. [Topotecan--a new principle of effectiveness in oncology. 4th Salzburg Symposium on Quality of Life. 15-17 December 1995].
    Geburtshilfe Frauenheilkd; 1996 Jun; 56(6 Suppl):1-6. PubMed ID: 9022377
    [No Abstract]   [Full Text] [Related]  

  • 20. [Single topotecan or in combination with other chemotherapeutic agents for 18 recurrent advanced ovarian cancer patients].
    Li H; Liu L; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):513-5. PubMed ID: 11859726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.